Skip to content

The prospective study of the effectiveness fety on Compound Shengmai Chenggu Capsule in the Treatment of osteonecrosis of the femeral head patient

The prospective study of the effectiveness fety on Compound Shengmai Chenggu Capsule in the Treatment of osteonecrosis of the femeral head patient

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPC-15007030
Enrollment
Unknown
Registered
2015-09-01
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteonecrosis of the femeral head

Interventions

Case series:Compound Shengmai Chenggu Capsule

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. The patient is confirmed diagnosis of ONFH; 2. Age ranges 18 to 50, regardless of gender; 3. Patients had not received tem treatment before come to our hospital willing to accept the treatment; 4. Patients who agree sign the consent agreement; 5. And to comply with the above four conditions can be incorporated the test cases.

Exclusion criteria

Exclusion criteria: 1. Ineligibility criteria; 2. Merger diabetes, thyroid disease, kidney disease of heart head blood-vessel, cancer, tumor diseases, diseases of the immune tem other serious primary disease or mental illness; 3. Merger affect bone metabolism disease, such as the elderly osteoarthropathy, bone dissolve, suppurative arthritis, tuberculosis, spinal tuberculosis, etc.; 4. Lactation or pregnancy women. 5.Cant keep this solution treatment or other treatment method. 6.Lack of adherence of patients. 7.Communication barriers in Chinese patients. 8.Meet the requirements for the above term 1 excluding test cases.

Design outcomes

Primary

MeasureTime frame
Anteroposterior Pelvis X-ray;Frog-Leg Lateral X-ray;CT imaging of hip;MRI imaging of hip;Harris score;VAS pain scroe;Life satisfaction score;Simple life quality evaluation scale, SF-12;

Countries

China

Contacts

Public ContactWei He
hw13802516062@126.com+86 13802516062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026